A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid

NCT06234462 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped challenges with recruitment

Conditions

Long COVID
Post-Acute COVID-19 Syndrome

Interventions

DRUG: Amantadine
OTHER: Physical, Occupational, Speech Therapy
OTHER: Provider Counseling
OTHER: Medications for symptoms management

Sponsor

University of Texas Southwestern Medical Center